Clinical trials: Safety, Tolerability, Pharmacokinetics of AEF0217

Safety, Tolerability, Pharmacokinetics of AEF0217

AEF0217 First-in-Human Phase I Study in 3 Parts (Single and Multiple Ascending Doses, and Food Effect) in Healthy Subjects.

• Completed
• Age: 18 to 55 years
• Phase 1

This trial is divided in 3 parts: FIH-SAD (Single Ascending Doses), FIH-MAD (Multiple Ascending Doses) and FIH-FE (Food effects). FIH-SAD will start first.

Trial name

AEF0217-101 (NCT05170737)

Testing

AEF0217

Where

Spain

Volunteers

68 people, healthy volunteers welcome

Sponsor

Aelis Farma